nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC22A8—Mercaptopurine—hematologic cancer	0.127	0.377	CbGbCtD
Cefotaxime—SLC22A11—Methotrexate—hematologic cancer	0.0714	0.212	CbGbCtD
Cefotaxime—SLC22A7—Methotrexate—hematologic cancer	0.068	0.202	CbGbCtD
Cefotaxime—SLC22A8—Methotrexate—hematologic cancer	0.0415	0.123	CbGbCtD
Cefotaxime—SLC22A6—Methotrexate—hematologic cancer	0.0289	0.0859	CbGbCtD
Cefotaxime—Cefazolin—PON1—hematologic cancer	0.00221	0.453	CrCbGaD
Cefotaxime—Cefdinir—MPO—hematologic cancer	0.000905	0.185	CrCbGaD
Cefotaxime—Cefaclor—MPO—hematologic cancer	0.000896	0.184	CrCbGaD
Cefotaxime—Cefazolin—ALB—hematologic cancer	0.000246	0.0504	CrCbGaD
Cefotaxime—Ceftriaxone—ALB—hematologic cancer	0.000233	0.0478	CrCbGaD
Cefotaxime—Malaise—Dexamethasone—hematologic cancer	0.000224	0.000341	CcSEcCtD
Cefotaxime—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000224	0.00034	CcSEcCtD
Cefotaxime—Pruritus—Alitretinoin—hematologic cancer	0.000224	0.00034	CcSEcCtD
Cefotaxime—Eosinophilia—Doxorubicin—hematologic cancer	0.000223	0.000339	CcSEcCtD
Cefotaxime—Arrhythmia—Prednisone—hematologic cancer	0.000222	0.000338	CcSEcCtD
Cefotaxime—Feeling abnormal—Cisplatin—hematologic cancer	0.000222	0.000337	CcSEcCtD
Cefotaxime—Pruritus—Ifosfamide—hematologic cancer	0.000221	0.000336	CcSEcCtD
Cefotaxime—Shock—Triamcinolone—hematologic cancer	0.00022	0.000335	CcSEcCtD
Cefotaxime—Nausea—Bortezomib—hematologic cancer	0.000219	0.000333	CcSEcCtD
Cefotaxime—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000219	0.000332	CcSEcCtD
Cefotaxime—Hypersensitivity—Irinotecan—hematologic cancer	0.000219	0.000332	CcSEcCtD
Cefotaxime—Vomiting—Thiotepa—hematologic cancer	0.000219	0.000332	CcSEcCtD
Cefotaxime—Diarrhoea—Carmustine—hematologic cancer	0.000218	0.000332	CcSEcCtD
Cefotaxime—Nausea—Bleomycin—hematologic cancer	0.000217	0.00033	CcSEcCtD
Cefotaxime—Rash—Thiotepa—hematologic cancer	0.000217	0.000329	CcSEcCtD
Cefotaxime—Dermatitis—Thiotepa—hematologic cancer	0.000216	0.000329	CcSEcCtD
Cefotaxime—Diarrhoea—Alitretinoin—hematologic cancer	0.000216	0.000329	CcSEcCtD
Cefotaxime—Agranulocytosis—Methotrexate—hematologic cancer	0.000216	0.000329	CcSEcCtD
Cefotaxime—Convulsion—Dexamethasone—hematologic cancer	0.000216	0.000328	CcSEcCtD
Cefotaxime—Convulsion—Betamethasone—hematologic cancer	0.000216	0.000328	CcSEcCtD
Cefotaxime—Headache—Thiotepa—hematologic cancer	0.000215	0.000327	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000215	0.000327	CcSEcCtD
Cefotaxime—Diarrhoea—Ifosfamide—hematologic cancer	0.000214	0.000325	CcSEcCtD
Cefotaxime—Nausea—Vinorelbine—hematologic cancer	0.000214	0.000325	CcSEcCtD
Cefotaxime—Renal failure—Epirubicin—hematologic cancer	0.000213	0.000324	CcSEcCtD
Cefotaxime—Body temperature increased—Cisplatin—hematologic cancer	0.000213	0.000324	CcSEcCtD
Cefotaxime—Jaundice—Epirubicin—hematologic cancer	0.000211	0.000321	CcSEcCtD
Cefotaxime—Vomiting—Thalidomide—hematologic cancer	0.000211	0.000321	CcSEcCtD
Cefotaxime—Pain—Etoposide—hematologic cancer	0.000211	0.000321	CcSEcCtD
Cefotaxime—Neutropenia—Doxorubicin—hematologic cancer	0.000211	0.00032	CcSEcCtD
Cefotaxime—Rash—Thalidomide—hematologic cancer	0.00021	0.000318	CcSEcCtD
Cefotaxime—Discomfort—Dexamethasone—hematologic cancer	0.000209	0.000318	CcSEcCtD
Cefotaxime—Discomfort—Betamethasone—hematologic cancer	0.000209	0.000318	CcSEcCtD
Cefotaxime—Dermatitis—Thalidomide—hematologic cancer	0.000209	0.000318	CcSEcCtD
Cefotaxime—Haemoglobin—Methotrexate—hematologic cancer	0.000209	0.000318	CcSEcCtD
Cefotaxime—Diarrhoea—Vincristine—hematologic cancer	0.000209	0.000317	CcSEcCtD
Cefotaxime—Headache—Thalidomide—hematologic cancer	0.000208	0.000316	CcSEcCtD
Cefotaxime—Pain—Prednisolone—hematologic cancer	0.000208	0.000316	CcSEcCtD
Cefotaxime—Haemorrhage—Methotrexate—hematologic cancer	0.000208	0.000316	CcSEcCtD
Cefotaxime—Hepatitis—Methotrexate—hematologic cancer	0.000208	0.000316	CcSEcCtD
Cefotaxime—Pruritus—Gemcitabine—hematologic cancer	0.000205	0.000311	CcSEcCtD
Cefotaxime—Cefalotin—ALB—hematologic cancer	0.000204	0.0419	CrCbGaD
Cefotaxime—Nausea—Thiotepa—hematologic cancer	0.000204	0.00031	CcSEcCtD
Cefotaxime—Feeling abnormal—Etoposide—hematologic cancer	0.000203	0.000309	CcSEcCtD
Cefotaxime—Anaphylactic shock—Betamethasone—hematologic cancer	0.000203	0.000309	CcSEcCtD
Cefotaxime—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000203	0.000309	CcSEcCtD
Cefotaxime—Diarrhoea—Mitoxantrone—hematologic cancer	0.000203	0.000309	CcSEcCtD
Cefotaxime—Diarrhoea—Irinotecan—hematologic cancer	0.000203	0.000309	CcSEcCtD
Cefotaxime—Vomiting—Carmustine—hematologic cancer	0.000203	0.000308	CcSEcCtD
Cefotaxime—Agranulocytosis—Epirubicin—hematologic cancer	0.000202	0.000308	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Etoposide—hematologic cancer	0.000202	0.000307	CcSEcCtD
Cefotaxime—Rash—Carmustine—hematologic cancer	0.000201	0.000306	CcSEcCtD
Cefotaxime—Ill-defined disorder—Prednisone—hematologic cancer	0.000201	0.000306	CcSEcCtD
Cefotaxime—Dermatitis—Carmustine—hematologic cancer	0.000201	0.000306	CcSEcCtD
Cefotaxime—Vomiting—Alitretinoin—hematologic cancer	0.000201	0.000306	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisolone—hematologic cancer	0.000201	0.000305	CcSEcCtD
Cefotaxime—Headache—Carmustine—hematologic cancer	0.0002	0.000304	CcSEcCtD
Cefotaxime—Shock—Betamethasone—hematologic cancer	0.0002	0.000304	CcSEcCtD
Cefotaxime—Shock—Dexamethasone—hematologic cancer	0.0002	0.000304	CcSEcCtD
Cefotaxime—Rash—Alitretinoin—hematologic cancer	0.000199	0.000303	CcSEcCtD
Cefotaxime—Dermatitis—Alitretinoin—hematologic cancer	0.000199	0.000303	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000199	0.000302	CcSEcCtD
Cefotaxime—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000199	0.000302	CcSEcCtD
Cefotaxime—Thrombocytopenia—Betamethasone—hematologic cancer	0.000199	0.000302	CcSEcCtD
Cefotaxime—Vomiting—Ifosfamide—hematologic cancer	0.000199	0.000302	CcSEcCtD
Cefotaxime—Hypersensitivity—Cisplatin—hematologic cancer	0.000199	0.000302	CcSEcCtD
Cefotaxime—Headache—Alitretinoin—hematologic cancer	0.000198	0.000301	CcSEcCtD
Cefotaxime—Angioedema—Prednisone—hematologic cancer	0.000198	0.000301	CcSEcCtD
Cefotaxime—Diarrhoea—Gemcitabine—hematologic cancer	0.000198	0.000301	CcSEcCtD
Cefotaxime—Nausea—Thalidomide—hematologic cancer	0.000197	0.0003	CcSEcCtD
Cefotaxime—Renal failure—Doxorubicin—hematologic cancer	0.000197	0.0003	CcSEcCtD
Cefotaxime—Rash—Ifosfamide—hematologic cancer	0.000197	0.000299	CcSEcCtD
Cefotaxime—Dermatitis—Ifosfamide—hematologic cancer	0.000197	0.000299	CcSEcCtD
Cefotaxime—Erythema multiforme—Methotrexate—hematologic cancer	0.000197	0.000299	CcSEcCtD
Cefotaxime—Urticaria—Etoposide—hematologic cancer	0.000196	0.000298	CcSEcCtD
Cefotaxime—Haemoglobin—Epirubicin—hematologic cancer	0.000196	0.000297	CcSEcCtD
Cefotaxime—Jaundice—Doxorubicin—hematologic cancer	0.000196	0.000297	CcSEcCtD
Cefotaxime—Malaise—Prednisone—hematologic cancer	0.000196	0.000297	CcSEcCtD
Cefotaxime—Abdominal pain—Etoposide—hematologic cancer	0.000195	0.000297	CcSEcCtD
Cefotaxime—Body temperature increased—Etoposide—hematologic cancer	0.000195	0.000297	CcSEcCtD
Cefotaxime—Haemorrhage—Epirubicin—hematologic cancer	0.000195	0.000296	CcSEcCtD
Cefotaxime—Hepatitis—Epirubicin—hematologic cancer	0.000195	0.000296	CcSEcCtD
Cefotaxime—Vomiting—Vincristine—hematologic cancer	0.000194	0.000294	CcSEcCtD
Cefotaxime—Urticaria—Prednisolone—hematologic cancer	0.000193	0.000294	CcSEcCtD
Cefotaxime—Rash—Vincristine—hematologic cancer	0.000192	0.000292	CcSEcCtD
Cefotaxime—Dermatitis—Vincristine—hematologic cancer	0.000192	0.000292	CcSEcCtD
Cefotaxime—Pain—Triamcinolone—hematologic cancer	0.000191	0.000291	CcSEcCtD
Cefotaxime—Headache—Vincristine—hematologic cancer	0.000191	0.00029	CcSEcCtD
Cefotaxime—Nausea—Carmustine—hematologic cancer	0.00019	0.000288	CcSEcCtD
Cefotaxime—Vomiting—Irinotecan—hematologic cancer	0.000189	0.000287	CcSEcCtD
Cefotaxime—Vomiting—Mitoxantrone—hematologic cancer	0.000189	0.000287	CcSEcCtD
Cefotaxime—Nausea—Alitretinoin—hematologic cancer	0.000188	0.000285	CcSEcCtD
Cefotaxime—Convulsion—Prednisone—hematologic cancer	0.000188	0.000285	CcSEcCtD
Cefotaxime—Agranulocytosis—Doxorubicin—hematologic cancer	0.000187	0.000285	CcSEcCtD
Cefotaxime—Rash—Mitoxantrone—hematologic cancer	0.000187	0.000284	CcSEcCtD
Cefotaxime—Rash—Irinotecan—hematologic cancer	0.000187	0.000284	CcSEcCtD
Cefotaxime—Dermatitis—Mitoxantrone—hematologic cancer	0.000187	0.000284	CcSEcCtD
Cefotaxime—Dermatitis—Irinotecan—hematologic cancer	0.000187	0.000284	CcSEcCtD
Cefotaxime—Headache—Mitoxantrone—hematologic cancer	0.000186	0.000283	CcSEcCtD
Cefotaxime—Headache—Irinotecan—hematologic cancer	0.000186	0.000283	CcSEcCtD
Cefotaxime—Cephalexin—ALB—hematologic cancer	0.000186	0.0381	CrCbGaD
Cefotaxime—Nausea—Ifosfamide—hematologic cancer	0.000186	0.000282	CcSEcCtD
Cefotaxime—Feeling abnormal—Triamcinolone—hematologic cancer	0.000185	0.00028	CcSEcCtD
Cefotaxime—Diarrhoea—Cisplatin—hematologic cancer	0.000184	0.00028	CcSEcCtD
Cefotaxime—Erythema multiforme—Epirubicin—hematologic cancer	0.000184	0.00028	CcSEcCtD
Cefotaxime—Vomiting—Gemcitabine—hematologic cancer	0.000184	0.000279	CcSEcCtD
Cefotaxime—Discomfort—Prednisone—hematologic cancer	0.000182	0.000277	CcSEcCtD
Cefotaxime—Rash—Gemcitabine—hematologic cancer	0.000182	0.000277	CcSEcCtD
Cefotaxime—Dermatitis—Gemcitabine—hematologic cancer	0.000182	0.000277	CcSEcCtD
Cefotaxime—Hypersensitivity—Etoposide—hematologic cancer	0.000182	0.000276	CcSEcCtD
Cefotaxime—Haemoglobin—Doxorubicin—hematologic cancer	0.000181	0.000275	CcSEcCtD
Cefotaxime—Headache—Gemcitabine—hematologic cancer	0.000181	0.000275	CcSEcCtD
Cefotaxime—Nausea—Vincristine—hematologic cancer	0.000181	0.000275	CcSEcCtD
Cefotaxime—Haemorrhage—Doxorubicin—hematologic cancer	0.00018	0.000274	CcSEcCtD
Cefotaxime—Hepatitis—Doxorubicin—hematologic cancer	0.00018	0.000274	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisolone—hematologic cancer	0.000179	0.000273	CcSEcCtD
Cefotaxime—Urticaria—Triamcinolone—hematologic cancer	0.000178	0.00027	CcSEcCtD
Cefotaxime—Body temperature increased—Triamcinolone—hematologic cancer	0.000177	0.000269	CcSEcCtD
Cefotaxime—Anaphylactic shock—Prednisone—hematologic cancer	0.000177	0.000269	CcSEcCtD
Cefotaxime—Nausea—Mitoxantrone—hematologic cancer	0.000176	0.000268	CcSEcCtD
Cefotaxime—Nausea—Irinotecan—hematologic cancer	0.000176	0.000268	CcSEcCtD
Cefotaxime—Pruritus—Etoposide—hematologic cancer	0.000175	0.000265	CcSEcCtD
Cefotaxime—Shock—Prednisone—hematologic cancer	0.000174	0.000265	CcSEcCtD
Cefotaxime—Arrhythmia—Epirubicin—hematologic cancer	0.000174	0.000264	CcSEcCtD
Cefotaxime—Pain—Dexamethasone—hematologic cancer	0.000174	0.000264	CcSEcCtD
Cefotaxime—Pain—Betamethasone—hematologic cancer	0.000174	0.000264	CcSEcCtD
Cefotaxime—Nausea—Gemcitabine—hematologic cancer	0.000172	0.000261	CcSEcCtD
Cefotaxime—Vomiting—Cisplatin—hematologic cancer	0.000171	0.00026	CcSEcCtD
Cefotaxime—Erythema multiforme—Doxorubicin—hematologic cancer	0.00017	0.000259	CcSEcCtD
Cefotaxime—Rash—Cisplatin—hematologic cancer	0.00017	0.000258	CcSEcCtD
Cefotaxime—Dermatitis—Cisplatin—hematologic cancer	0.00017	0.000258	CcSEcCtD
Cefotaxime—Diarrhoea—Etoposide—hematologic cancer	0.000169	0.000257	CcSEcCtD
Cefotaxime—Ill-defined disorder—Methotrexate—hematologic cancer	0.000168	0.000255	CcSEcCtD
Cefotaxime—Feeling abnormal—Betamethasone—hematologic cancer	0.000167	0.000254	CcSEcCtD
Cefotaxime—Feeling abnormal—Dexamethasone—hematologic cancer	0.000167	0.000254	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000166	0.000252	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000166	0.000252	CcSEcCtD
Cefotaxime—Hypersensitivity—Triamcinolone—hematologic cancer	0.000165	0.000251	CcSEcCtD
Cefotaxime—Malaise—Methotrexate—hematologic cancer	0.000163	0.000248	CcSEcCtD
Cefotaxime—Leukopenia—Methotrexate—hematologic cancer	0.000162	0.000246	CcSEcCtD
Cefotaxime—Urticaria—Dexamethasone—hematologic cancer	0.000161	0.000245	CcSEcCtD
Cefotaxime—Urticaria—Betamethasone—hematologic cancer	0.000161	0.000245	CcSEcCtD
Cefotaxime—Arrhythmia—Doxorubicin—hematologic cancer	0.000161	0.000245	CcSEcCtD
Cefotaxime—Body temperature increased—Dexamethasone—hematologic cancer	0.000161	0.000244	CcSEcCtD
Cefotaxime—Abdominal pain—Betamethasone—hematologic cancer	0.000161	0.000244	CcSEcCtD
Cefotaxime—Abdominal pain—Dexamethasone—hematologic cancer	0.000161	0.000244	CcSEcCtD
Cefotaxime—Body temperature increased—Betamethasone—hematologic cancer	0.000161	0.000244	CcSEcCtD
Cefotaxime—Nausea—Cisplatin—hematologic cancer	0.00016	0.000243	CcSEcCtD
Cefotaxime—Pruritus—Triamcinolone—hematologic cancer	0.000158	0.000241	CcSEcCtD
Cefotaxime—Ill-defined disorder—Epirubicin—hematologic cancer	0.000157	0.000239	CcSEcCtD
Cefotaxime—Convulsion—Methotrexate—hematologic cancer	0.000157	0.000239	CcSEcCtD
Cefotaxime—Vomiting—Etoposide—hematologic cancer	0.000157	0.000238	CcSEcCtD
Cefotaxime—Rash—Etoposide—hematologic cancer	0.000156	0.000237	CcSEcCtD
Cefotaxime—Dermatitis—Etoposide—hematologic cancer	0.000156	0.000236	CcSEcCtD
Cefotaxime—Headache—Etoposide—hematologic cancer	0.000155	0.000235	CcSEcCtD
Cefotaxime—Rash—Prednisolone—hematologic cancer	0.000154	0.000233	CcSEcCtD
Cefotaxime—Dermatitis—Prednisolone—hematologic cancer	0.000153	0.000233	CcSEcCtD
Cefotaxime—Malaise—Epirubicin—hematologic cancer	0.000153	0.000232	CcSEcCtD
Cefotaxime—Headache—Prednisolone—hematologic cancer	0.000153	0.000232	CcSEcCtD
Cefotaxime—Discomfort—Methotrexate—hematologic cancer	0.000152	0.000232	CcSEcCtD
Cefotaxime—Leukopenia—Epirubicin—hematologic cancer	0.000152	0.000231	CcSEcCtD
Cefotaxime—Anaphylactic shock—Methotrexate—hematologic cancer	0.000148	0.000225	CcSEcCtD
Cefotaxime—Convulsion—Epirubicin—hematologic cancer	0.000147	0.000223	CcSEcCtD
Cefotaxime—Nausea—Etoposide—hematologic cancer	0.000147	0.000223	CcSEcCtD
Cefotaxime—Feeling abnormal—Prednisone—hematologic cancer	0.000146	0.000222	CcSEcCtD
Cefotaxime—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000146	0.000221	CcSEcCtD
Cefotaxime—Thrombocytopenia—Methotrexate—hematologic cancer	0.000145	0.00022	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Prednisone—hematologic cancer	0.000145	0.00022	CcSEcCtD
Cefotaxime—Nausea—Prednisolone—hematologic cancer	0.000145	0.00022	CcSEcCtD
Cefotaxime—Pruritus—Betamethasone—hematologic cancer	0.000144	0.000218	CcSEcCtD
Cefotaxime—Pruritus—Dexamethasone—hematologic cancer	0.000144	0.000218	CcSEcCtD
Cefotaxime—Discomfort—Epirubicin—hematologic cancer	0.000143	0.000217	CcSEcCtD
Cefotaxime—Vomiting—Triamcinolone—hematologic cancer	0.000142	0.000216	CcSEcCtD
Cefotaxime—Malaise—Doxorubicin—hematologic cancer	0.000141	0.000215	CcSEcCtD
Cefotaxime—Rash—Triamcinolone—hematologic cancer	0.000141	0.000215	CcSEcCtD
Cefotaxime—Dermatitis—Triamcinolone—hematologic cancer	0.000141	0.000214	CcSEcCtD
Cefotaxime—Urticaria—Prednisone—hematologic cancer	0.000141	0.000214	CcSEcCtD
Cefotaxime—Leukopenia—Doxorubicin—hematologic cancer	0.00014	0.000213	CcSEcCtD
Cefotaxime—Headache—Triamcinolone—hematologic cancer	0.00014	0.000213	CcSEcCtD
Cefotaxime—Body temperature increased—Prednisone—hematologic cancer	0.00014	0.000213	CcSEcCtD
Cefotaxime—Abdominal pain—Prednisone—hematologic cancer	0.00014	0.000213	CcSEcCtD
Cefotaxime—Diarrhoea—Betamethasone—hematologic cancer	0.000139	0.000211	CcSEcCtD
Cefotaxime—Diarrhoea—Dexamethasone—hematologic cancer	0.000139	0.000211	CcSEcCtD
Cefotaxime—Anaphylactic shock—Epirubicin—hematologic cancer	0.000138	0.00021	CcSEcCtD
Cefotaxime—Shock—Epirubicin—hematologic cancer	0.000136	0.000207	CcSEcCtD
Cefotaxime—Convulsion—Doxorubicin—hematologic cancer	0.000136	0.000207	CcSEcCtD
Cefotaxime—Thrombocytopenia—Epirubicin—hematologic cancer	0.000135	0.000206	CcSEcCtD
Cefotaxime—Nausea—Triamcinolone—hematologic cancer	0.000133	0.000202	CcSEcCtD
Cefotaxime—Discomfort—Doxorubicin—hematologic cancer	0.000132	0.000201	CcSEcCtD
Cefotaxime—Hypersensitivity—Prednisone—hematologic cancer	0.00013	0.000198	CcSEcCtD
Cefotaxime—Vomiting—Betamethasone—hematologic cancer	0.000129	0.000196	CcSEcCtD
Cefotaxime—Vomiting—Dexamethasone—hematologic cancer	0.000129	0.000196	CcSEcCtD
Cefotaxime—Rash—Betamethasone—hematologic cancer	0.000128	0.000195	CcSEcCtD
Cefotaxime—Rash—Dexamethasone—hematologic cancer	0.000128	0.000195	CcSEcCtD
Cefotaxime—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000128	0.000195	CcSEcCtD
Cefotaxime—Dermatitis—Betamethasone—hematologic cancer	0.000128	0.000194	CcSEcCtD
Cefotaxime—Dermatitis—Dexamethasone—hematologic cancer	0.000128	0.000194	CcSEcCtD
Cefotaxime—Headache—Betamethasone—hematologic cancer	0.000127	0.000193	CcSEcCtD
Cefotaxime—Headache—Dexamethasone—hematologic cancer	0.000127	0.000193	CcSEcCtD
Cefotaxime—Pain—Methotrexate—hematologic cancer	0.000126	0.000192	CcSEcCtD
Cefotaxime—Shock—Doxorubicin—hematologic cancer	0.000126	0.000191	CcSEcCtD
Cefotaxime—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000125	0.00019	CcSEcCtD
Cefotaxime—Pruritus—Prednisone—hematologic cancer	0.000125	0.00019	CcSEcCtD
Cefotaxime—Feeling abnormal—Methotrexate—hematologic cancer	0.000122	0.000185	CcSEcCtD
Cefotaxime—Diarrhoea—Prednisone—hematologic cancer	0.000121	0.000184	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000121	0.000184	CcSEcCtD
Cefotaxime—Nausea—Dexamethasone—hematologic cancer	0.000121	0.000183	CcSEcCtD
Cefotaxime—Nausea—Betamethasone—hematologic cancer	0.000121	0.000183	CcSEcCtD
Cefotaxime—Pain—Epirubicin—hematologic cancer	0.000118	0.00018	CcSEcCtD
Cefotaxime—Urticaria—Methotrexate—hematologic cancer	0.000117	0.000178	CcSEcCtD
Cefotaxime—Abdominal pain—Methotrexate—hematologic cancer	0.000117	0.000178	CcSEcCtD
Cefotaxime—Body temperature increased—Methotrexate—hematologic cancer	0.000117	0.000178	CcSEcCtD
Cefotaxime—Feeling abnormal—Epirubicin—hematologic cancer	0.000114	0.000173	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000113	0.000172	CcSEcCtD
Cefotaxime—Vomiting—Prednisone—hematologic cancer	0.000113	0.000171	CcSEcCtD
Cefotaxime—Rash—Prednisone—hematologic cancer	0.000112	0.00017	CcSEcCtD
Cefotaxime—Dermatitis—Prednisone—hematologic cancer	0.000111	0.000169	CcSEcCtD
Cefotaxime—Headache—Prednisone—hematologic cancer	0.000111	0.000168	CcSEcCtD
Cefotaxime—Urticaria—Epirubicin—hematologic cancer	0.00011	0.000167	CcSEcCtD
Cefotaxime—Pain—Doxorubicin—hematologic cancer	0.000109	0.000166	CcSEcCtD
Cefotaxime—Abdominal pain—Epirubicin—hematologic cancer	0.000109	0.000166	CcSEcCtD
Cefotaxime—Body temperature increased—Epirubicin—hematologic cancer	0.000109	0.000166	CcSEcCtD
Cefotaxime—Hypersensitivity—Methotrexate—hematologic cancer	0.000109	0.000166	CcSEcCtD
Cefotaxime—Feeling abnormal—Doxorubicin—hematologic cancer	0.000106	0.00016	CcSEcCtD
Cefotaxime—Nausea—Prednisone—hematologic cancer	0.000105	0.00016	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000105	0.000159	CcSEcCtD
Cefotaxime—Pruritus—Methotrexate—hematologic cancer	0.000105	0.000159	CcSEcCtD
Cefotaxime—Hypersensitivity—Epirubicin—hematologic cancer	0.000102	0.000155	CcSEcCtD
Cefotaxime—Urticaria—Doxorubicin—hematologic cancer	0.000102	0.000155	CcSEcCtD
Cefotaxime—Abdominal pain—Doxorubicin—hematologic cancer	0.000101	0.000154	CcSEcCtD
Cefotaxime—Body temperature increased—Doxorubicin—hematologic cancer	0.000101	0.000154	CcSEcCtD
Cefotaxime—Diarrhoea—Methotrexate—hematologic cancer	0.000101	0.000154	CcSEcCtD
Cefotaxime—Pruritus—Epirubicin—hematologic cancer	9.79e-05	0.000149	CcSEcCtD
Cefotaxime—Diarrhoea—Epirubicin—hematologic cancer	9.47e-05	0.000144	CcSEcCtD
Cefotaxime—Hypersensitivity—Doxorubicin—hematologic cancer	9.43e-05	0.000143	CcSEcCtD
Cefotaxime—Vomiting—Methotrexate—hematologic cancer	9.4e-05	0.000143	CcSEcCtD
Cefotaxime—Rash—Methotrexate—hematologic cancer	9.32e-05	0.000142	CcSEcCtD
Cefotaxime—Dermatitis—Methotrexate—hematologic cancer	9.32e-05	0.000142	CcSEcCtD
Cefotaxime—Headache—Methotrexate—hematologic cancer	9.26e-05	0.000141	CcSEcCtD
Cefotaxime—Pruritus—Doxorubicin—hematologic cancer	9.06e-05	0.000138	CcSEcCtD
Cefotaxime—Vomiting—Epirubicin—hematologic cancer	8.8e-05	0.000134	CcSEcCtD
Cefotaxime—Nausea—Methotrexate—hematologic cancer	8.78e-05	0.000133	CcSEcCtD
Cefotaxime—Diarrhoea—Doxorubicin—hematologic cancer	8.76e-05	0.000133	CcSEcCtD
Cefotaxime—Rash—Epirubicin—hematologic cancer	8.73e-05	0.000133	CcSEcCtD
Cefotaxime—Dermatitis—Epirubicin—hematologic cancer	8.72e-05	0.000132	CcSEcCtD
Cefotaxime—Headache—Epirubicin—hematologic cancer	8.67e-05	0.000132	CcSEcCtD
Cefotaxime—Nausea—Epirubicin—hematologic cancer	8.22e-05	0.000125	CcSEcCtD
Cefotaxime—Vomiting—Doxorubicin—hematologic cancer	8.14e-05	0.000124	CcSEcCtD
Cefotaxime—Rash—Doxorubicin—hematologic cancer	8.07e-05	0.000123	CcSEcCtD
Cefotaxime—Dermatitis—Doxorubicin—hematologic cancer	8.07e-05	0.000123	CcSEcCtD
Cefotaxime—Headache—Doxorubicin—hematologic cancer	8.02e-05	0.000122	CcSEcCtD
Cefotaxime—Nausea—Doxorubicin—hematologic cancer	7.61e-05	0.000116	CcSEcCtD
